tradingkey.logo
tradingkey.logo
Search

LB Pharmaceuticals Inc

LBRX
Add to Watchlist
43.010USD
+0.550+1.30%
Close 11-13 16:00(ET)
1.39BMarket Cap
LossP/E TTM

About LB Pharmaceuticals Inc Company

LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. The Company is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a Phase III-ready oral, small molecule for the treatment of acute schizophrenia, defined as a sudden and severe episode of psychotic symptoms, characterized by hallucinations, delusions, and other positive symptoms. The Company is also developing a long-acting injectable, or LAI, formulation of LB-102, which improves compliance, a common issue in patients with schizophrenia and bipolar disorder.

LB Pharmaceuticals Inc Profile

Ticker SymbolLBRX
Company nameLB Pharmaceuticals Inc
IPO dateSep 11, 2025
CEOTurner (Heather D)
Number of employees16
Security typeOrdinary Share
Fiscal year-endSep 11
AddressOne Pennsylvania Plaza, Suite 1025
CityNEW YORK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code10119
Phone19174506581
Websitehttps://lbpharma.us/
Ticker SymbolLBRX
IPO dateSep 11, 2025
CEOTurner (Heather D)

Company Executives of LB Pharmaceuticals Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Zachary Prensky
Mr. Zachary Prensky
Co-Founder, Director
Co-Founder, Director
61.27K
--
Mr. Marc L. Panoff, CPA
Mr. Marc L. Panoff, CPA
Senior Vice President - Finance
Senior Vice President - Finance
10.24K
--
Dr. Robert R. Ruffolo, Jr.
Dr. Robert R. Ruffolo, Jr.
Independent Director
Independent Director
--
--
Dr. Susan G. Kozauer, M.D.
Dr. Susan G. Kozauer, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Joseph Miller
Mr. Joseph Miller
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher (Chris) Zergebel
Mr. Christopher (Chris) Zergebel
Senior Vice President - Clinical Operations
Senior Vice President - Clinical Operations
--
--
Ms. Kaya Pai Panandiker
Ms. Kaya Pai Panandiker
Chief Commercial Officer
Chief Commercial Officer
--
--
Dr. Robert A. (Rob) Lenz, M.D., Ph.D.
Dr. Robert A. (Rob) Lenz, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. James Rawls
Dr. James Rawls
Senior Vice President - Regulatory Affairs
Senior Vice President - Regulatory Affairs
--
--
Ms. Rekha Hemrajani
Ms. Rekha Hemrajani
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Zachary Prensky
Mr. Zachary Prensky
Co-Founder, Director
Co-Founder, Director
61.27K
--
Mr. Marc L. Panoff, CPA
Mr. Marc L. Panoff, CPA
Senior Vice President - Finance
Senior Vice President - Finance
10.24K
--
Dr. Robert R. Ruffolo, Jr.
Dr. Robert R. Ruffolo, Jr.
Independent Director
Independent Director
--
--
Dr. Susan G. Kozauer, M.D.
Dr. Susan G. Kozauer, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Joseph Miller
Mr. Joseph Miller
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Christopher (Chris) Zergebel
Mr. Christopher (Chris) Zergebel
Senior Vice President - Clinical Operations
Senior Vice President - Clinical Operations
--
--

FAQs

Who are the top five shareholders of LB Pharmaceuticals Inc?

The top five shareholders of LB Pharmaceuticals Inc are: Mr. Zachary Prensky
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.